A case report of a pregnancy complicated by very long chain acyl CoA dehydrogenase deficiency(myopathic form)
-
- Endo Eisaku
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Obata Mana
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Miyashiro Yumeko
- Mito Saiseikai General Hospital, Department of Obstetrics and Gynecology
-
- Teruya Hiromi
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Adachi Yuka
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Nishida Keiko
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Iiba Moe
- Mito Saiseikai General Hospital, Department of Obstetrics and Gynecology
-
- Mayumi Miyuki
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Abe Haruna
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Ohara Rena
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Hamada Hiromi
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
-
- Satoh Toyomi
- University of Tsukuba, Faculty of Medicine, Department of Obstetrics and Gynecology
Bibliographic Information
- Other Title
-
- 極長鎖アシルCoA脱水素酵素欠損症(骨格筋型)合併妊娠の一例
Search this article
Abstract
<p> Very long-chain acyl CoA dehydrogenase(VLCAD)deficiency is a congenital abnormality in which mitochondrial fatty acid metabolism is altered. Patients present with myalgia, muscle weakness and rhabdomyolysis in hyper-catabolic states, such as prolonged fasting and intense exercise. There are few reports of VLCAD deficiency in pregnancy, and its management is unclear. In this report, we describe the management of a patient with VLCAD deficiency(myopathic form)during pregnancy. The patient was a 27-year-old, primigravida woman with a history of rhabdomyolysis following appendectomy at the age of 25 years. In early pregnancy, she presented with hyperemesis gravidarum that was successfully treated with administration of glucose-containing infusions. At 39 weeks and 4 days of gestation, the patient went into labor and admitted. She received intravenous glucose(5% solution)continuously from the time of admission until 3 days after the spontaneous vaginal delivery. Although she had a mildly elevated creatine kinase level on the day of delivery, she did not present with myalgia, muscle weakness, or rhabdomyolysis. It was, thus, suggested that timely glucose infusion may have prevented worsening of her symptoms.</p>
Journal
-
- Journal of Japan Society of Perinatal and Neonatal Medicine
-
Journal of Japan Society of Perinatal and Neonatal Medicine 57 (1), 205-208, 2021
Japan Society of Perinatal and Neonatal Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390006507987816320
-
- NII Article ID
- 130008036665
-
- ISSN
- 24354996
- 1348964X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed